Tag: Cognitive decline

news-04082024-230958

Uncovering the Reality of Novel Alzheimer’s Medications

In early July, the US Food and Drug Administration (FDA) approved a new treatment called donanemab for individuals with early-stage Alzheimer’s disease. This medication is the second drug that has been proven to slow...
news-04082024-225407

Improving Alzheimer’s Blood Tests for Diagnosis: Progress and Challenges

Alzheimer’s disease can be difficult to diagnose, but recent research suggests that proteins in the blood could offer a solution. At the annual Alzheimer’s Association International Conference in Philadelphia, new findings were presented, indicating...